Ali Behbahani Genocea Biosciences, Inc. (GNCA) insider trading activity

GNCA Quotes by TradingView

Ali Behbahani Transaction History

Date Transaction Value Shares Traded Form
May 25 2022
SELL
Open market or private sale
$355,607 $0.08 p/Share
4,445,093
May 24 2022
SELL
Open market or private sale
$415,229 $0.07 p/Share
5,931,843

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
RGLS
Regulus Therapeutics Inc. Healthcare
> 10% Shareholder
MRKR
Marker Therapeutics, Inc. Healthcare
> 10% Shareholder
BDTX
Black Diamond Therapeutics, Inc. Healthcare
OYST
Oyster Point Pharma, Inc. Healthcare
Director
NKTX
Nkarta, Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
CVRX
CVRx, Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
TRVI
Trevi Therapeutics, Inc. Healthcare
> 10% Shareholder
UTRS
MINERVA SURGICAL INC Healthcare
Director
MTCR
Metacrine, Inc. Healthcare
> 10% Shareholder
AKUS
Akouos, Inc. Healthcare
> 10% Shareholder
ACLX
Arcellx, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
SVRA
Savara Inc Healthcare
> 10% Shareholder
FREQ
Frequency Therapeutics, Inc. Healthcare
AB

Ali Behbahani

Director
Timonium, MD

Track Institutional and Insider Activities on GNCA

Follow GENOCEA BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GNCA shares.

Notify only if

Insider Trading

Get notified when an Genocea Biosciences, Inc. insider buys or sells GNCA shares.

Notify only if

News

Receive news related to GENOCEA BIOSCIENCES, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GNCA